PROMETHEUS BIOSCIENCES, INC. Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent
PROMETHEUS BIOSCIENCES, INC. reported Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent of -$141.75 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Income Statement › Net Income
us-gaap:IncomeLossFromContinuingOperations · last filed 2023-02-28
- PROMETHEUS BIOSCIENCES, INC. income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2021-12-31 was -$29.92M.
- PROMETHEUS BIOSCIENCES, INC. income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2021-09-30 was -$27.33M.
- PROMETHEUS BIOSCIENCES, INC. income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2021-06-30 was -$19.00M.
- PROMETHEUS BIOSCIENCES, INC. income (loss) from continuing operations, net of tax, attributable to parent for the quarter ending 2021-03-31 was -$13.95M.
- PROMETHEUS BIOSCIENCES, INC. income (loss) from continuing operations, net of tax, attributable to parent for fiscal 2022 was -$141.75M.
- PROMETHEUS BIOSCIENCES, INC. income (loss) from continuing operations, net of tax, attributable to parent for fiscal 2021 was -$90.19M.
- PROMETHEUS BIOSCIENCES, INC. income (loss) from continuing operations, net of tax, attributable to parent for fiscal 2020 was -$31.14M.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 3 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 6 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 9 month | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$141.75M 10-K · filed 2023-02-28 | |||
| 2021-12-31 | -$29.92M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$57.25M derived: sum of 2 quarters · filed 2023-02-28 | -$76.25M derived: sum of 3 quarters · filed 2023-02-28 | -$90.19M 10-K · filed 2023-02-28 |
| 2021-09-30 | -$27.33M 10-Q · filed 2021-11-12 | -$46.33M derived: sum of 2 quarters · filed 2021-11-12 | -$60.28M 10-Q · filed 2021-11-12 | -$69.48M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$19.00M 10-Q · filed 2021-08-11 | -$32.94M 10-Q · filed 2021-08-11 | -$42.15M derived: sum of 3 quarters · filed 2023-02-28 | -$49.98M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$13.95M 10-Q · filed 2021-05-13 | -$23.15M derived: sum of 2 quarters · filed 2023-02-28 | -$30.98M derived: sum of 3 quarters · filed 2023-02-28 | -$38.13M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$9.21M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$17.03M derived: sum of 2 quarters · filed 2023-02-28 | -$24.18M derived: sum of 3 quarters · filed 2023-02-28 | -$31.14M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$7.83M 10-Q · filed 2021-11-12 | -$14.98M derived: sum of 2 quarters · filed 2021-11-12 | -$21.93M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | -$7.15M 10-Q · filed 2021-08-11 | -$14.11M 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | -$6.95M 10-Q · filed 2021-05-13 |